|
[ About the Section
| Responsibilities | Key Personnel |
Quality Assurance | Key Instruments
| Targets
and Key Indicators ]
[ Previous | Next
]
Chinese Medicines Section
About the
Section
|
This Section was established on 7th October
1998. Its major responsibilities are to carry out safety monitoring
of proprietary Chinese medicines and Chinese herbal medicines
on sale to the public and to conduct development work on analytical
methodology. |
Responsibilities
This Section examines Proprietary Chinese Medicines
and Chinese herbal medicines submitted by the Department of Health.
Proprietary Chinese medicines and Chinese herbal medicines are analyzed for their safety and quality including the determination of pesticide residues and heavy metals/toxic element. Analytical services were also provided to DH in relation to the investigation into the causes of poisoning cases and reports of adverse drug reactions involving the consumption of Chinese medicines.
For the HOKLAS accredited tests undertaken by this section, please click here for details.
Key Personnel
Senior Chemist : Mr. C S Ng
(Tel. No.: 2319-8398 E-mail : csng@govtlab.gov.hk)
Quality
Assurance
About 10% of the tests conducted in the Section
are for QC purposes.
Key
Instruments
|
The following instruments are used routinely
by the Section:
-
Gas chromatograph with Electron Capture Detector, Flame Photometric Detector and Mass Selective Detector
-
High Performance Liquid Chromatographs with Evaporative Light Scattering Detector, Photodiode Array Detector and Scanning Fluorescence Detector
-
UV Spectrophotometer
-
Fourier Transform Infrared Spectrophotometer
-
High Performance Liquid Chromatograph - Ion Trap Mass Spectrometer
-
High Performance Liquid Chromatograph - Tandem Mass spectrometer
-
Inductively Coupled Plasma - Mass Spectrometer
|
Targets
and Key Indicators
Key Performance Measures Relating to the Statutory
Testing of Chinese Medicines
Targets
| Testing of Chinese Medicines |
Targets |
2009
(Actual) |
2010
(Actual) |
2011
(Plan) |
Chinese Medicines
within reporting time
averaging 30 working days (%)* |
95 |
99 |
98 |
95 |
|
| * |
Different samples require different analytical procedures, thus different reporting time applies. The quoted number of working days required represents an average of reporting time for the different types of samples / test requests within the category, while the target (in percentage) is the total compliance rate of the concerned samples / test requests within a particular category against their respective targets. |
Key Indicators
Key Indicators for Statutory Testing of Chinese
Medicines
| Tests Performed on Chinese
Medicines |
2009
(Actual) |
2010
(Actual) |
2011
(Estimate) |
| Chinese Medicines |
68,864 |
95,890 |
78,800 |
|
|
